DIDREX Drug Patent Profile
✉ Email this page to a colleague
When do Didrex patents expire, and when can generic versions of Didrex launch?
Didrex is a drug marketed by Pfizer and is included in one NDA.
The generic ingredient in DIDREX is benzphetamine hydrochloride. There are nine drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the benzphetamine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Didrex
A generic version of DIDREX was approved as benzphetamine hydrochloride by KVK TECH on July 20th, 2010.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DIDREX?
- What are the global sales for DIDREX?
- What is Average Wholesale Price for DIDREX?
Summary for DIDREX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 11 |
| Patent Applications: | 1,427 |
| DailyMed Link: | DIDREX at DailyMed |
US Patents and Regulatory Information for DIDREX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer | DIDREX | benzphetamine hydrochloride | TABLET;ORAL | 012427-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pfizer | DIDREX | benzphetamine hydrochloride | TABLET;ORAL | 012427-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
